Mind Medicine (MindMed) (OTCMKTS:MMEDF) Shares Climb 1.2% – Still a Buy?

Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report)’s stock price shot up 1.2% during trading on Friday. The stock traded as high as $29.98 and last traded at $29.48. Approximately 3,074,414 shares traded hands during trading, a decline of 9% from the average session volume of 3,376,665 shares. The stock had previously closed at $29.12.

Mind Medicine (MindMed) Stock Down 3.9%

The business’s 50-day moving average is $35.52 and its two-hundred day moving average is $30.60.

About Mind Medicine (MindMed)

(Get Free Report)

Mind Medicine (MindMed) is a clinical-stage biopharmaceutical company developing treatments for brain health disorders. Its research focuses on drug candidates inspired by psychedelic and related compounds, with the goal of addressing unmet needs in mental health care. The company’s lead candidate, MM-120, is a pharmaceutical formulation of lysergide being studied for conditions including generalized anxiety disorder and major depressive disorder. MindMed has also pursued other investigational compounds, including candidates based on research into psychedelic substances and their potential therapeutic effects.

Further Reading

Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.